DMAC vs KIM · $157.4M cap vs P/E 27, $16.03B cap
DiaMedica Therapeutics Inc (DMAC) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
DMAC does not have a complete income-statement cache yet.
KIM does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the DMAC and KIM stock pages for the full models.
Not investment advice.